A recent study examined the benefits of extending warfarin therapy for an additional 18 months after an initial six-month treatment period.
The state of Illinois will launch a pilot program next year to try to answer that question.
More than 7 out of 10 Americans believe that drug costs are unreasonable and drug companies place profits before people, according to a recent Kaiser Health Tracking poll.
Florida’s crackdown on pill mills has resulted in decreases in opioid prescriptions, according to an online study published by JAMA Internal Medicine.
CVS Health recently introduced a new pharmacy service, ScriptSync, designed to enable patients with multiple Rxs to pick them up during one visit to the pharmacy.
CVS/Caremark and Express Scripts, the two biggest players in the pharmacy benefits management industry, have both added medications to their exclusion lists.
The picture looks somewhat better than it did a year ago, but many challenges remain.